Source link : https://www.newshealth.biz/health-news/mezigdomide-combinations-show-promise-in-multiple-myeloma/
The phase I/II CA057-003 trial presented at the American Society of Hematology annual meeting showed promising results with novel mezigdomide-based combinations in relapsed or refractory multiple myeloma. In this exclusive MedPage Today video, David Samuel Dicapua Siegel, MD, of the John Theurer Cancer Center in Hackensack, New Jersey, discusses the potential for this investigational small […]
Author : News Health
Publish date : 2024-12-27 15:09:56
Copyright for syndicated content belongs to the linked Source.